아그마틴 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "아그마틴" in Korean language version.

refsWebsite

Global rank Korean rank

19doi.org

2^nd place

3^rd place

17nih.gov

4^th place

1ebi.ac.uk

5,849^th place

955^th place

1mpg.de

1,624^th place

786^th place

1oed.com

360^th place

348^th place

1zenodo.org

621^st place

732^nd place

1worldcat.org

5^th place

11^th place

1semanticscholar.org

11^th place

310^th place

1web.archive.org

1^st place

1chinaphar.com

low place

chinaphar.com

Su RB, Li J, Qin BY (July 2003). “A biphasic opioid function modulator: agmatine” (PDF). 《Acta Pharmacologica Sinica》 24 (7): 631–6. PMID 12852826. 2020년 11월 8일에 원본 문서 (PDF)에서 보존된 문서. 2020년 4월 22일에 확인함.

doi.org

dx.doi.org

Kossel A (1910). “Über das Agmatin”. 《Zeitschrift für Physiologische Chemie》 (독일어) 66 (3): 257–261. doi:10.1515/bchm2.1910.66.3.257.
Engeland R, Kutscher F (1910). “Ueber eine zweite wirksame Secale-base.”. 《Z Physiol Chem》 (독일어) 57: 49–65. doi:10.1515/bchm2.1908.57.1-2.49.
Dale HH, Laidlaw PP (October 1911). “Further observations on the action of beta-iminazolylethylamine”. 《The Journal of Physiology》 43 (2): 182–95. doi:10.1113/jphysiol.1911.sp001464. PMC 1512691. PMID 16993089.
Frank E, Nothmann M, Wagner A (1926). “über Synthetisch Dargestellte Körper mit Insulinartiger Wirkung Auf den Normalen und Diabetischen Organismus”. 《Klinische Wochenschrift》 (독일어) 5 (45): 2100–2107. doi:10.1007/BF01736560.
Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ (February 1994). “Agmatine: an endogenous clonidine-displacing substance in the brain”. 《Science》 263 (5149): 966–9. doi:10.1126/science.7906055. PMID 7906055.
Piletz JE, Aricioglu F, Cheng JT, Fairbanks CA, Gilad VH, Haenisch B, Halaris A, Hong S, Lee JE, Li J, Liu P, Molderings GJ, Rodrigues AL, Satriano J, Seong GJ, Wilcox G, Wu N, Gilad GM (September 2013). “Agmatine: clinical applications after 100 years in translation”. 《Drug Discovery Today》 18 (17–18): 880–93. doi:10.1016/j.drudis.2013.05.017. PMID 23769988.
Galea, Elena; Regunathan, S.; Eliopoulos, Vassily; Feinstein, Douglas L.; Reis, Donald J. (1996년 5월 15일). “Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine”. 《Biochemical Journal》 (영어) 316 (1): 247–249. doi:10.1042/bj3160247. ISSN 0264-6021. PMC 1217329. PMID 8645212.
Gadkari TV, Cortes N, Madrasi K, Tsoukias NM, Joshi MS (November 2013). “Agmatine induced NO dependent rat mesenteric artery relaxation and its impairment in salt-sensitive hypertension”. 《Nitric Oxide》 35: 65–71. doi:10.1016/j.niox.2013.08.005. PMC 3844099. PMID 23994446.
Demady DR, Jianmongkol S, Vuletich JL, Bender AT, Osawa Y (January 2001). “Agmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzyme”. 《Molecular Pharmacology》 59 (1): 24–9. doi:10.1124/mol.59.1.24. PMID 11125020.
Taksande BG, Kotagale NR, Nakhate KT, Mali PD, Kokare DM, Hirani K, Subhedar NK, Chopde CT, Ugale RR (September 2011). “Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y”. 《British Journal of Pharmacology》 164 (2b): 704–18. doi:10.1111/j.1476-5381.2011.01484.x. PMC 3188911. PMID 21564088.
Gilad GM, Gilad VH (December 2013). “Evidence for oral agmatine sulfate safety--a 95-day high dosage pilot study with rats”. 《Food and Chemical Toxicology》 62: 758–62. doi:10.1016/j.fct.2013.10.005. PMID 24140462.
Nissim I, Horyn O, Daikhin Y, Chen P, Li C, Wehrli SL, Nissim I, Yudkoff M (April 2014). “The molecular and metabolic influence of long term agmatine consumption”. 《The Journal of Biological Chemistry》 289 (14): 9710–29. doi:10.1074/jbc.M113.544726. PMC 3975019. PMID 24523404.
Galgano F, Caruso M, Condelli N, Favati F (2012년 6월 7일). “Focused review: agmatine in fermented foods”. 《Frontiers in Microbiology》 3: 199. doi:10.3389/fmicb.2012.00199. PMC 3369198. PMID 22701114.
Haenisch B, von Kügelgen I, Bönisch H, Göthert M, Sauerbruch T, Schepke M, Marklein G, Höfling K, Schröder D, Molderings GJ (November 2008). “Regulatory mechanisms underlying agmatine homeostasis in humans”. 《American Journal of Physiology. Gastrointestinal and Liver Physiology》 295 (5): G1104–10. doi:10.1152/ajpgi.90374.2008. PMID 18832451.
Huisman H, Wynveen P, Nichkova M, Kellermann G (August 2010). “Novel ELISAs for screening of the biogenic amines GABA, glycine, beta-phenylethylamine, agmatine, and taurine using one derivatization procedure of whole urine samples”. 《Analytical Chemistry》 82 (15): 6526–33. doi:10.1021/ac100858u. PMID 20586417.
Halaris A, Plietz J (2007). “Agmatine : metabolic pathway and spectrum of activity in brain”. 《CNS Drugs》 21 (11): 885–900. doi:10.2165/00023210-200721110-00002. PMID 17927294.
Raasch W, Schäfer U, Chun J, Dominiak P (July 2001). “Biological significance of agmatine, an endogenous ligand at imidazoline binding sites”. 《British Journal of Pharmacology》 133 (6): 755–80. doi:10.1038/sj.bjp.0704153. PMC 1572857. PMID 11454649.
Satriano J (July 2004). “Arginine pathways and the inflammatory response: interregulation of nitric oxide and polyamines: review article”. 《Amino Acids》 26 (4): 321–9. doi:10.1007/s00726-004-0078-4. PMID 15290337.
Marc RE (April 1999). “Mapping glutamatergic drive in the vertebrate retina with a channel-permeant organic cation”. 《The Journal of Comparative Neurology》 407 (1): 47–64. doi:10.1002/(sici)1096-9861(19990428)407:1<47::aid-cne4>3.0.co;2-0. PMID 10213187.

ebi.ac.uk

“agmatine (CHEBI:17431)”. 《Chemical Entities of Biological Interest》. UK: European Bioinformatics Institute. 2008년 8월 15일. Main. 2012년 1월 11일에 확인함.

mpg.de

vlp.mpiwg-berlin.mpg.de

Kossel A (1910). “Über das Agmatin”. 《Zeitschrift für Physiologische Chemie》 (독일어) 66 (3): 257–261. doi:10.1515/bchm2.1910.66.3.257.

nih.gov

ncbi.nlm.nih.gov

Dale HH, Laidlaw PP (October 1911). “Further observations on the action of beta-iminazolylethylamine”. 《The Journal of Physiology》 43 (2): 182–95. doi:10.1113/jphysiol.1911.sp001464. PMC 1512691. PMID 16993089.
Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ (February 1994). “Agmatine: an endogenous clonidine-displacing substance in the brain”. 《Science》 263 (5149): 966–9. doi:10.1126/science.7906055. PMID 7906055.
Piletz JE, Aricioglu F, Cheng JT, Fairbanks CA, Gilad VH, Haenisch B, Halaris A, Hong S, Lee JE, Li J, Liu P, Molderings GJ, Rodrigues AL, Satriano J, Seong GJ, Wilcox G, Wu N, Gilad GM (September 2013). “Agmatine: clinical applications after 100 years in translation”. 《Drug Discovery Today》 18 (17–18): 880–93. doi:10.1016/j.drudis.2013.05.017. PMID 23769988.
Galea, Elena; Regunathan, S.; Eliopoulos, Vassily; Feinstein, Douglas L.; Reis, Donald J. (1996년 5월 15일). “Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine”. 《Biochemical Journal》 (영어) 316 (1): 247–249. doi:10.1042/bj3160247. ISSN 0264-6021. PMC 1217329. PMID 8645212.
Gadkari TV, Cortes N, Madrasi K, Tsoukias NM, Joshi MS (November 2013). “Agmatine induced NO dependent rat mesenteric artery relaxation and its impairment in salt-sensitive hypertension”. 《Nitric Oxide》 35: 65–71. doi:10.1016/j.niox.2013.08.005. PMC 3844099. PMID 23994446.
Demady DR, Jianmongkol S, Vuletich JL, Bender AT, Osawa Y (January 2001). “Agmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzyme”. 《Molecular Pharmacology》 59 (1): 24–9. doi:10.1124/mol.59.1.24. PMID 11125020.
Taksande BG, Kotagale NR, Nakhate KT, Mali PD, Kokare DM, Hirani K, Subhedar NK, Chopde CT, Ugale RR (September 2011). “Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y”. 《British Journal of Pharmacology》 164 (2b): 704–18. doi:10.1111/j.1476-5381.2011.01484.x. PMC 3188911. PMID 21564088.
Gilad GM, Gilad VH (December 2013). “Evidence for oral agmatine sulfate safety--a 95-day high dosage pilot study with rats”. 《Food and Chemical Toxicology》 62: 758–62. doi:10.1016/j.fct.2013.10.005. PMID 24140462.
Nissim I, Horyn O, Daikhin Y, Chen P, Li C, Wehrli SL, Nissim I, Yudkoff M (April 2014). “The molecular and metabolic influence of long term agmatine consumption”. 《The Journal of Biological Chemistry》 289 (14): 9710–29. doi:10.1074/jbc.M113.544726. PMC 3975019. PMID 24523404.
Galgano F, Caruso M, Condelli N, Favati F (2012년 6월 7일). “Focused review: agmatine in fermented foods”. 《Frontiers in Microbiology》 3: 199. doi:10.3389/fmicb.2012.00199. PMC 3369198. PMID 22701114.
Haenisch B, von Kügelgen I, Bönisch H, Göthert M, Sauerbruch T, Schepke M, Marklein G, Höfling K, Schröder D, Molderings GJ (November 2008). “Regulatory mechanisms underlying agmatine homeostasis in humans”. 《American Journal of Physiology. Gastrointestinal and Liver Physiology》 295 (5): G1104–10. doi:10.1152/ajpgi.90374.2008. PMID 18832451.
Huisman H, Wynveen P, Nichkova M, Kellermann G (August 2010). “Novel ELISAs for screening of the biogenic amines GABA, glycine, beta-phenylethylamine, agmatine, and taurine using one derivatization procedure of whole urine samples”. 《Analytical Chemistry》 82 (15): 6526–33. doi:10.1021/ac100858u. PMID 20586417.
Halaris A, Plietz J (2007). “Agmatine : metabolic pathway and spectrum of activity in brain”. 《CNS Drugs》 21 (11): 885–900. doi:10.2165/00023210-200721110-00002. PMID 17927294.
Raasch W, Schäfer U, Chun J, Dominiak P (July 2001). “Biological significance of agmatine, an endogenous ligand at imidazoline binding sites”. 《British Journal of Pharmacology》 133 (6): 755–80. doi:10.1038/sj.bjp.0704153. PMC 1572857. PMID 11454649.
Satriano J (July 2004). “Arginine pathways and the inflammatory response: interregulation of nitric oxide and polyamines: review article”. 《Amino Acids》 26 (4): 321–9. doi:10.1007/s00726-004-0078-4. PMID 15290337.
Marc RE (April 1999). “Mapping glutamatergic drive in the vertebrate retina with a channel-permeant organic cation”. 《The Journal of Comparative Neurology》 407 (1): 47–64. doi:10.1002/(sici)1096-9861(19990428)407:1<47::aid-cne4>3.0.co;2-0. PMID 10213187.
Su RB, Li J, Qin BY (July 2003). “A biphasic opioid function modulator: agmatine” (PDF). 《Acta Pharmacologica Sinica》 24 (7): 631–6. PMID 12852826. 2020년 11월 8일에 원본 문서 (PDF)에서 보존된 문서. 2020년 4월 22일에 확인함.

oed.com

〈agmantine〉. 《옥스퍼드 영어사전》 온라인판. 옥스퍼드 대학교 출판부. (구독 또는 참여 기관 회원가입 필요)

semanticscholar.org

Demady DR, Jianmongkol S, Vuletich JL, Bender AT, Osawa Y (January 2001). “Agmatine enhances the NADPH oxidase activity of neuronal NO synthase and leads to oxidative inactivation of the enzyme”. 《Molecular Pharmacology》 59 (1): 24–9. doi:10.1124/mol.59.1.24. PMID 11125020.

web.archive.org

Su RB, Li J, Qin BY (July 2003). “A biphasic opioid function modulator: agmatine” (PDF). 《Acta Pharmacologica Sinica》 24 (7): 631–6. PMID 12852826. 2020년 11월 8일에 원본 문서 (PDF)에서 보존된 문서. 2020년 4월 22일에 확인함.

worldcat.org

Galea, Elena; Regunathan, S.; Eliopoulos, Vassily; Feinstein, Douglas L.; Reis, Donald J. (1996년 5월 15일). “Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine”. 《Biochemical Journal》 (영어) 316 (1): 247–249. doi:10.1042/bj3160247. ISSN 0264-6021. PMC 1217329. PMID 8645212.

zenodo.org

Engeland R, Kutscher F (1910). “Ueber eine zweite wirksame Secale-base.”. 《Z Physiol Chem》 (독일어) 57: 49–65. doi:10.1515/bchm2.1908.57.1-2.49.